Zdrowie i gospodarka · 19/08/2013

FDA Clears LIDEX and LIDEX-E for Sale, Citing Lack of Safety or Effectiveness Concerns

The US Food and Drug Administration (FDA) has announced that it will not withdraw approval of abbreviated new drug applications (ANDAs) for LIDEX (fluocinonide) Cream and LIDEX-E (fluocinonide) Cream, as well as nine other drug products, due to concerns over safety or effectiveness.